Pseudomonas aeruginosa에 의한 요로감염의 임상적 특성 = The Clinical Features of Complicated Urinary Tract Infections by Pseudomonas aeruginosa

다국어 초록 (Multilingual Abstract)

Purpose: Pseudomonas aeruginosa is an important pathogen in complicated urinary tract infections(UTIs). The aim of this study was to evaluate the isolation rate of Pseudomonas from patients with UTIs and to define the accompanying clinical features.
Materials and Methods: Between January 2000 and December 2006, we retrospectively reviewed the medical records of 170 urology patients with Pseudomonas UTIs. We analyzed the isolation rate of Pseudomonas in patients with UTIs and determined the antibiotic susceptibilities. We also analyzed the clinical features and underlying diseases in patients with Pseudomonas UTIs.
Results: Pseudomonas was cultured in the urine from 234 of 3,470 patients (6.6%) with positive urine cultures. One hundred seventy of 234 patients had underlying urologic disease. Eighty-two patients(48.2%) had indwelling urinary catheters and 34 patients(20.0%) had diabetes. Patients with catheters tended to have febrile UTIs compared to patients without catheters(70.7% vs. 42.0%, respectively). The isolation rate of Pseudomonas increased between 2000 and 2006(2.8% vs. 13.1%, respectively). The sensitivity of Pseudomonas to most antibiotics decreased between 2000 and 2006. Patients with neurogenic disease and catheters were more easily infected with Pseudomonas.
Conclusions: The isolation rate of Pseudomonas in urine cultures is on the rise. Patients with UTIs and catheters, unlike those without, have high fevers. Because the sensitivity of Pseudomonas to antimicrobial agents has decreased, we need to choose appropriate antibiotics through urine cultures and antibiotics sensitivity tests in treating complicated UTIs.

다국어 초록 (Multilingual Abstract)

Purpose: Pseudomonas aeruginosa is an important pathogen in complicated urinary tract infections(UTIs). The aim of this study was to evaluate the isolation rate of Pseudomonas from patients with UTIs and to define the accompanying clinical features.
Materials and Methods: Between January 2000 and December 2006, we retrospectively reviewed the medical records of 170 urology patients with Pseudomonas UTIs. We analyzed the isolation rate of Pseudomonas in patients with UTIs and determined the antibiotic susceptibilities. We also analyzed the clinical features and underlying diseases in patients with Pseudomonas UTIs.
Results: Pseudomonas was cultured in the urine from 234 of 3,470 patients (6.6%) with positive urine cultures. One hundred seventy of 234 patients had underlying urologic disease. Eighty-two patients(48.2%) had indwelling urinary catheters and 34 patients(20.0%) had diabetes. Patients with catheters tended to have febrile UTIs compared to patients without catheters(70.7% vs. 42.0%, respectively). The isolation rate of Pseudomonas increased between 2000 and 2006(2.8% vs. 13.1%, respectively). The sensitivity of Pseudomonas to most antibiotics decreased between 2000 and 2006. Patients with neurogenic disease and catheters were more easily infected with Pseudomonas.
Conclusions: The isolation rate of Pseudomonas in urine cultures is on the rise. Patients with UTIs and catheters, unlike those without, have high fevers. Because the sensitivity of Pseudomonas to antimicrobial agents has decreased, we need to choose appropriate antibiotics through urine cultures and antibiotics sensitivity tests in treating complicated UTIs.

참고문헌 (Reference)

1 유광호, "최근 요로감염증의 주요 원인균과 항생제 감수성에 관한 고찰" 대한비뇨기과학회 48 (48): 638-645, 2007

2 송호준, "요로감염의 원인균에 따른 항생제 감수성에 관한 고찰" 대한비뇨기과학회 46 (46): 68-73, 2005

3 이점규, "국내 1, 2차 의료기관의 임상검체에서 분리된 Pseudomonas aeruginosa 항균제 내성, 2002-2004" 대한감염학회 38 (38): 1-10, 2006

4 Cordero L, "Ventilator-associated pneumonia in very low-birth-weight infants at the time of nosocomial bloodstream infection and during airway colonization with Pseudomonas aeruginosa" 28 : 333-9, 2000

5 Naber KG, "The management of urinary and genital tract infections ; In European association of urology" European Association of Urology Guidelines 1-1269, 2006

6 Pollack M, "Pseudomonas aeruginosa ; In Mandell, Douglas and Bennett’s principles and practice of infectious diseases. 5th ed" Philadelphia: Churchill Livingstone 2310-2335, 2000

7 Ono Y, "Pseudomonas aeruginosa" 60 : 2150-5, 2002

8 National Nosocomial Infections Surveillance System, "National Nosocomial Infections Surveillance(NNIS) system report, data, summary from January 1992 through June 2004, issued October 2004" 32 : 470-485, 2004

9 National Committee for Clinical Laboratory Standards, "Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically"

10 Mulholland SG, "Management of urinary tract infections" 1 : 1-8, 1982

11 Jones RN, "Geographic variations in activity of broad-spectrum beta- lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program(1997-2000)" 43 : 239-43, 2002

12 Mathai D, "Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program(North America)" 40 : 129-136, 2001

13 Shigemura K, "Complicated urinary tract infection caused by Pseudomonas aeruginosa in a single institution(1999-2003)" 13 : 538-42, 2006

14 Kumon H, "Combination effect of fosfomycin and ofloxacin against Pseudomonas aeruginosa growing in a biofilm" 39 : 1038-44, 1995

15 Gupta K, "Antimicrobial resistance among uropathogens that cause community-acquired urinary infections in women: a nationwide analysis" 33 : 89-94, 2001

16 Spencer RC, "An 8 year microbe base survey of the epidemiology, frequency and antibiotic susceptibility of Pseudomonas aeruginosa hospital isolates in the United Kingdom" 37 : 295-301, 1996